The Bio/Pharma Beat

    View Authors September 2019

    We would like to share with you the Bio/Pharma Beat, our monthly newsletter reporting on the patent law developments you should know in biotech, biologics and pharmaceutical cases, legislation and federal agency actions. This month’s issue covers relevant news from August 2019, including:

    • Two Federal Circuit decisions concerning the “tangential relationship” exception to prosecution history estoppel
    • A district court decision rejecting a forward-looking analysis regarding the “acts of infringement” for determining proper venue in ANDA cases
    • A district court decision on JMOL, holding antibody claims met the “representative species” test for written description, but were invalid for lack of enablement
    • A district court opinion by Judge Bryson, sitting by designation, regarding infringement under the doctrine of equivalents